Autopsy report · NCT03504501
Synaptic Plasticity and Cognitive Function in RASopathies
Cause of deathSlow enrollment
“The study has been terminated prematurely due to recruitment difficulties. Current status: recruitment stopped and cleaning of the database is ongoing.”
Life of this trial
- Registered 11 months before it started.
- Ran for about 4 years 7 months before it stopped.
- 16 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Technical University of Munich
- Sponsor type
- University, hospital or other
- Conditions
- Impaired Synaptic Plasticity; Impaired Cognition
- Interventions
- Lovastatin; Lamotrigine
- Participants
- 16
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
“The study was terminated due to recruitment challenges” - Early Versus Late Amniotomy Following EAB Cervical Ripening
“Study was terminated due to difficulties in recruitment” - Alfuzosin Versus Placebo in Acute Urinary Retention
“The study was early terminated due to slow and difficult recruitment” - THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
“Study terminated due to slow recruitment.” - Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery
“The study was terminated due to a considerably lower recruitment rate than anticipated”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.